Handelsavisen
prelaunch
ST
STRO.OL Oslo Børs Computer Hardware

Strongpoint ASA

kr10,65
Open in Charts → Attach watcher ⌖
NOK
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
476,9M NOK
P/E
EV / Rev
1,2x
Div yield
0,00 %
Op margin
-6,6 %
ROE
-4,7 %
Net margin
-7,1 %
Debt / equity
0,47
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Strongpoint ASA is a provider of computer hardware and peripherals, generating revenue primarily through the design, development, and sale of technology equipment.

Business. Strongpoint ASA (STRO.OL) is a technology company operating in the computer hardware industry, specifically engaged in the sale of computers and peripherals. The firm is headquartered in Norway and is listed on the Oslo Stock Exchange under the ticker STRO.OL. Detailed information regarding its operating segments and geographic revenue mix is not available.

Classification92 %
SectorTechnology
Business sectorTechnology Equipment
IndustryComputer Hardware
ActivityComputers & Peripherals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
43
composite score
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-4,7 %
return on equity
Quality
59
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning STRO.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,2 %+1,6 %+2,4 %
    Energy+1,2 %+5,3 %+1,4 %
    Real Estate+0,7 %+4,1 %+0,8 %
    Health Care+0,7 %−0,5 %+0,8 %
    Consumer Discretionary+0,3 %+8,7 %+0,5 %
    Information Technology · THIS SECTOR−0,3 %+6,6 %−0,1 %
    Financials−0,3 %−4,5 %−0,1 %
    Consumer Staples−1,0 %+3,0 %−0,8 %
    Utilities−1,5 %−21,2 %−1,3 %
    Industrials−1,7 %−2,3 %−1,6 %
    Communication Services

    Developing storylines

    No tracked sagas currently linked to STRO.OL. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-07 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score43 / 100
    Composite score 0-100 · Data quality 0,59
    Data quality0,59 / 1.00

    Synthesis

    Business

    Strongpoint ASA (STRO.OL) is a technology company operating in the computer hardware industry, specifically engaged in the sale of computers and peripherals. The firm is headquartered in Norway and is listed on the Oslo Stock Exchange under the ticker STRO.OL. Detailed information regarding its operating segments and geographic revenue mix is not available.

    Classification92 %
    SectorTechnology
    Business sectorTechnology Equipment
    IndustryComputer Hardware
    ActivityComputers & Peripherals
    AI synthesis
    GENERATED

    Strongpoint ASA has a market capitalization of NOK 1.37 billion and a price-to-book ratio of 3.03, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 1.16, suggesting limited short-term liquidity cushion, while its cash and equivalents of NOK 25.6 million are insufficient to cover its long-term debt of NOK 213.3 million. Free cash flow is negative at NOK -19.4 million, reflecting operational cash outflows after capital expenditures.

    Profitability metrics show a challenging performance, with a net loss of NOK 21.2 million and an operating loss of NOK 19.6 million in the latest reporting period. Return on equity is negative at -4.67%, and return on assets is also negative at -2.22%, indicating poor capital efficiency and asset utilization. Gross profit of NOK 130.9 million represents 44% of revenue, which is below the industry median for computer hardware firms, suggesting margin compression or competitive pricing pressures.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic shifts and customer concentration risks. No material geographic breakdown is available in the input data, but the absence of international revenue reporting is notable.

    Looking ahead, revenue is projected to grow to NOK 1.5 billion in the next fiscal year, a 9.1% increase from the current NOK 1.36 billion. However, the company is expected to continue reporting negative earnings, with a mean EPS estimate of -NOK 0.35. Analysts have set a mean price target of NOK 25.00, which is below the current market price of NOK 30.62, suggesting a bearish outlook.

    Risk factors include a negative net cash position after subtracting total debt, which raises concerns about liquidity and financial flexibility. The company's debt-to-equity ratio of 0.47 is relatively low, but the negative free cash flow and operating cash flow of NOK 5.6 million indicate limited capacity to service debt or fund growth initiatives. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments.

    Recent filings and transcripts show no material changes in the company's strategic direction or capital structure. The latest earnings report highlights continued investment in R&D and product development, but these efforts have not yet translated into profitability. Analysts remain cautious, with all price targets below the current market price, reflecting skepticism about the company's ability to sustain its valuation.

    Key takeaways
    • Strongpoint ASA is trading at a premium to book value (P/B of 3.03), but with negative earnings and operating cash flow.
    • The company's liquidity position is weak, with a current ratio of 1.16 and negative net cash after debt.
    • Gross profit margin of 44% is below industry medians, indicating margin compression or pricing pressures.
    • Analysts have set a mean price target of NOK 25.00, below the current market price of NOK 30.62, signaling a bearish outlook.
    • Revenue is expected to grow by 9.1% in the next fiscal year, but earnings are projected to remain negative.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 2

    Analysts project 135.8% upside to a consensus price target of 25.0 NOK, significantly above the current market price of 10.6 NOK.

    Revenue grew at an 8.5% compound annual growth rate over the four-year period ending in FY2026.

    BEAR CASE · 3

    The company faces high credit risk and medium liquidity risk, with a current ratio of only 0.70 as of late 2025.

    Operating and net margins rank in the bottom quartile of the Computer Hardware cohort, indicating poor profitability relative to peers.

    Cash conversion is negative at -0.26, falling below the cohort median of 1.0 and highlighting weak cash generation efficiency.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-04-29
    Q1 2026 · Quarter highlights

    Revenue kr 342.3M, −1,2% YoY; Operating income −74,9% YoY.

    Revenuekr 342.3M−1,2 % YoY
    Operating income-kr 656.0k−74,9 % YoY
    Net income-kr 8.5M−2,1 % YoY
    Free cash flow-kr 4.8M+44,3 % YoY
    EPS
    Operating cash flow-kr 9.0M−207,9 % YoY
    Financials
    Income statement
    Revenuekr 342.3M
    Gross profitkr 153.2M
    Operating income-kr 656.0k
    Net income-kr 8.5M
    Margins
    Gross margin44.8%
    Operating margin-0.2%
    Net margin-2.5%
    FCF margin-1.4%
    Balance sheet
    Total assetskr 958.8M
    Total liabilitieskr 510.6M
    Total equitykr 448.1M
    Cash & equivalentskr 67.6M
    Long-term debtkr 218.0M
    Cash flow
    Operating cash flow-kr 9.0M
    CapEx-kr 7.0M
    Free cash flow-kr 4.8M
    SBC
    P&L flow · revenue → net income
    Revenue kr 342.3MOperating costs kr 343.0MTax kr 7.8MNet income kr 8.5M
    Highlights
    • Revenue kr 342.3M, −1,2% YoY
    • Operating income −74,9% YoY
    • Net income −2,1% YoY
    • Free cash flow +44,3% YoY
    • Net margin -2.5%

    Valuation TTM

    Market price
    kr10,65
    Market cap
    kr1.37B
    Enterprise value
    kr1.56B
    P/E
    Non-GAAP P/E
    EV / Revenue
    1.2x
    EV / Op income
    EV / OCF
    279.1x
    P / B
    3.0x
    P / Tangible book
    3.0x
    Tangible book
    kr452.7M
    Net cash
    -kr187.7M
    Current ratio
    1.2
    Debt / equity
    0.5
    ROA
    -2.2%
    ROE
    -4.7%
    Cash conversion
    -26.0%
    CapEx / revenue
    -5.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryPharmaceuticals & Medical Research15,2B node revenueKLAR 23,0%BNTX 21,4%EXEL 15,2%MDGL 6,3%INSM 4,0%VCYT 3,4%MDXG 2,8%AVIR 2,3%Other 21,6%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)STRO 0,7% · rank #19 of 109

    Business relationships

    Business relationships6 disclosed relationships · 1 type · extracted from filings & disclosures
    Partners6
    MERCK & CO., INC.MRK.OPartner95%Source ↗
    Merck KgaaMRK.DEPartner95%Source ↗
    Tasly Pharmaceutical Group600535.SSPartner90%Source ↗
    Vaxcyte, Inc.PCVX.OPartner90%Source ↗

    Supply chain

    Vendors → STRO ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSSTROSTROStrongpoint ASA6 entitiesAstellas Pharma IncPharmaceuticalsJPBristol-myers Squibb CUnclassifiedUSMERCK & CO., INC.USMerck KgaaDETasly Pharmaceutical GUnclassifiedCNVaxcyte, Inc.Biotechnology & Medical US
    6 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    Peer comparison8 peers · vs STRO · multiples and returns
    KL
    KLAR
    KLAR.ST
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    BN
    BNTX
    Biontech SE
    $94,00
    23,8B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    EX
    EXEL
    Exelixis Inc
    $55,56
    14,1B USD
    P/E
    347,8x
    vs self
    Div yield
    vs self
    ROE
    1,8 %
    -142,5 vs self
    MD
    MDGL
    Madrigal Pharmaceuticals Inc
    $529,48
    12,2B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -47,8 %
    -192,1 vs self
    IN
    INSM
    Insmed Inc
    $112,00
    24,2B USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    33,8 %
    -110,5 vs self
    VC
    VCYT
    Veracyte Inc
    $57,99
    4,6B USD
    P/E
    54,3x
    vs self
    Div yield
    vs self
    ROE
    5,1 %
    -139,2 vs self
    MD
    MDXG
    Mimedx Group Inc
    $4,07
    606,2M USD
    P/E
    11,1x
    vs self
    Div yield
    vs self
    ROE
    18,9 %
    -125,3 vs self
    AV
    AVIR
    Atea Pharmaceuticals Inc
    $4,87
    P/E
    vs self
    Div yield
    vs self
    ROE
    -57,5 %
    -201,8 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,35
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-16 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-0,35
    Revenueno estimateno estimate1,5B NOK
    Operating incomeno estimateno estimate-12,0M NOK
    Full-year consensus mean (period as reported by source) · consensus in NOK. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-07-07

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    12-month price targetkr25,00 · Median kr25,00
    Low kr25,00High kr25,00
    Operating income · consensus-12,0M NOK
    EPS surprise
    +145,7 %
    reported vs consensus · beat
    Revenue surprise
    −9,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Lowkr25,00
    Meankr25,00
    Mediankr25,00
    Highkr25,00
    Spotkr10,65
    +134.7 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-6,6 %Bottom quartile
    Net Margin-7,1 %Bottom quartile
    ROE-4,7 %Bottom quartile
    Capex / Rev-5,1 %Bottom quartile
    D/E0,47Below median
    Cash Conv-0,26Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Strongpoint ASA Market data — financials · 2026-05-29
    • Strongpoint ASA Market data — analyst estimates · 2026-05-29
    • Strongpoint ASA Market data — ESG · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    STRO.OLCanonical
    Oslo Børs · NOK

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    STRO4503.TBMY.OMRK.OMRK.DE600535.SPCVX.OComputer Hardw
    This companySectorPartners

    Evidence & claims

    From filings & derived data
    • Return on assets (FY 2024-12-31): -1.0%Derived (calculated)
    • Debt-to-equity (FY 2024-12-31): 0.71xDerived (calculated)
    • Current ratio (FY 2024-12-31): 0.35xDerived (calculated)
    • Return on equity (FY 2024-12-31): -1.7%Derived (calculated)
    • Net margin (FY 2024-12-31): -47.3%Derived (calculated)
    • Revenue (annual): NOK 14.49MBRREG filing
    • Shareholders' equity (annual): NOK 406.7MBRREG filing
    • Total equity & liabilities (annual): NOK 693.63MBRREG filing
    • Total liabilities (annual): NOK 286.93MBRREG filing
    • Net income (annual): NOK -6.86MBRREG filing
    • Pre-tax income (annual): NOK -9.34MBRREG filing
    • Operating income (annual): NOK -12.02MBRREG filing
    • Non current liabilities (annual): NOK 0BRREG filing
    • Total operating expenses (annual): NOK 26.5MBRREG filing
    • Total assets (annual): NOK 693.63MBRREG filing
    • Current assets (annual): NOK 100.79MBRREG filing
    • Current liabilities (annual): NOK 286.93MBRREG filing
    • Non current assets (annual): NOK 592.84MBRREG filing
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-08FILING8-K filing →
    2026-06-05 00:00 UTCINSIDER10 insider transactions — 2026-06 9 derivative
    2026-06-05INSIDERDybbs Michael acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERWigginton Jon Marc acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERPetree Daniel H acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERPANEK JAMES P acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERLobacki Joseph M acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERJagpal Sukhi acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERHunter Heidi acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-05INSIDERMATSUI CONNIE acquired 10.0k sh Stock Option (right to buy) — Director
    2026-06-04 04:04 UTCFILINGRegulatory filing →
    2026-06-02INSIDERChow Gregory K. transacted 2.5k sh — CFO
    2026-06-02INSIDERChow Gregory K. disposed of 2.5k sh Restricted Stock Units (RSUs) — CFO
    2026-05-21 05:24 UTCFILINGRegulatory filing →
    2026-05-14FILING10-Q filing →
    2026-05-14FILING8-K filing →
    2026-04-29 06:01 UTCEARNINGSQuarterly results — Q1 2026 Revenue NOK 342.3M · Net NOK -8.5M
    2026-04-22FILINGDEF 14A filing →
    2026-04-01FILING424B3 filing →
    2026-03-23FILING10-K filing →
    2026-03-23FILING8-K filing →
    2026-03-04 00:00 UTCINSIDER36 insider transactions — 2026-03 · net sell $160k 18 derivative
    2026-03-04INSIDERChung Jane transacted 282 sh — Director, Chief Executive Officer ~$6k
    2026-03-04INSIDERPauling David transacted 675 sh — Chief Admin. Ofcr. & GC
    2026-03-04INSIDERPauling David transacted 277 sh — Chief Admin. Ofcr. & GC ~$6k
    2026-03-04INSIDERChung Jane transacted 788 sh — Director, Chief Executive Officer
    2026-03-04INSIDERChung Jane disposed of 788 sh Restricted Stock Units (RSUs) — Director, Chief Executive Officer
    2026-03-04INSIDERPauling David disposed of 675 sh Restricted Stock Units (RSUs) — Chief Admin. Ofcr. & GC
    2026-03-02INSIDERGerber Hans-Peter transacted 2.8k sh — CHIEF SCIENTIFIC OFFICER
    2026-03-02INSIDERChung Jane transacted 7.8k sh — Director, Chief Executive Officer
    2026-03-02INSIDERChung Jane transacted 2.8k sh — Director, Chief Executive Officer ~$57k
    2026-03-02INSIDERGerber Hans-Peter transacted 1.2k sh — CHIEF SCIENTIFIC OFFICER ~$24k
    2026-03-02INSIDERPauling David transacted 2.4k sh — Chief Admin. Ofcr. & GC
    2026-03-02INSIDERPauling David transacted 970 sh — Chief Admin. Ofcr. & GC ~$20k
    2026-03-02INSIDERChung Jane acquired 175.0k sh Stock Option (right to buy) — Director, Chief Executive Officer
    2026-03-02INSIDERPauling David disposed of 2.4k sh Restricted Stock Units (RSUs) — Chief Admin. Ofcr. & GC
    2026-03-02INSIDERPauling David acquired 4.2k sh Restricted Stock Units (RSUs) — Chief Admin. Ofcr. & GC
    Showing the 40 most recent of 73 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage